# SMNRW (Semnur Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Semnur Pharmaceuticals, Inc. reported $2.01M in total assets and a net loss of $18.71M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/SMNRW
- Markdown: https://convexityos.com/fundamentals/SMNRW.md
- SEC CIK: 0001913577
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:49 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001913577&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$18.54M | Operating profit |
| Net Income | FY 2025 | -$18.71M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.08 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $54K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Research & Development | $2.55M | $1.71M | -- | -- |
| Total Operating Expenses | $160.4M | $4.69M | -- | -- |
| **Operating Income** | -$160.4M | -$4.69M | -$3.17M | -- |
| **EBITDA** | -$160.4M | -$4.69M | -- | -- |
| Interest Income | -- | $1.58M | $3.84M | $1.22M |
| Interest Expense | -- | $96K | $37K | -- |
| Income Before Tax | $0 | $0 | -- | -- |
| Income Tax Expense | $0 | $0 | -- | -- |
| **Net Income** | -$160.4M | -$4.69M | $633K | -$419K |
| Basic EPS | -$0.78 | -$0.02 | -- | -- |
| **Diluted EPS** | -$0.78 | -$0.02 | -- | -- |
| Basic Shares Outstanding | 204.8M | 200.0M | -- | -- |
| Diluted Shares Outstanding | 204.8M | 200.0M | -- | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.44M | $1.25M | $1.27M | $714K | $1.14M | $502K | $187K | -- |
| Total Operating Expenses | $3.58M | $4.22M | $4.58M | $6.16M | $152.6M | $999K | $665K | -- |
| **Operating Income** | -$3.58M | -$4.22M | -$4.58M | -$6.16M | -$152.6M | -$999K | -$665K | -$776K |
| **EBITDA** | -$3.58M | -$4.22M | -$4.58M | -$6.16M | -$152.6M | -$999K | -$665K | -- |
| Interest Income | -- | -- | -- | -- | -- | $18K | $79K | $87K |
| Interest Expense | $56K | $123K | -- | -- | $0 | $28K | $27K | $27K |
| **Net Income** | -$3.63M | -$4.35M | -$4.58M | -$6.16M | -$152.6M | -$999K | -$665K | -$167K |
| Basic EPS | -$0.02 | -$0.02 | -$0.02 | -- | -$0.76 | -$0.01 | -$0.01 | -- |
| **Diluted EPS** | -$0.02 | -$0.02 | -$0.02 | -- | -$0.76 | -$0.01 | -$0.01 | -- |
| Basic Shares Outstanding | 224.2M | 230.2M | 230.2M | -- | 201.7M | 200.0M | 200.0M | -- |
| Diluted Shares Outstanding | 224.2M | 230.2M | 230.2M | -- | 201.7M | 200.0M | 200.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $20K | $12K | $204K | $820K |
| **Cash & Short-Term Investments** | $20K | $12K | $204K | $820K |
| Other Current Assets | $0 | $5.98M | -- | -- |
| **Total Current Assets** | $596K | $6.00M | $209K | $908K |
| Property, Plant & Equipment, Net | $750K | $689K | -- | -- |
| **Total Non-Current Assets** | $750K | $689K | $50.48M | $85.37M |
| **Total Assets** | $1.35M | $6.68M | $50.69M | $86.28M |
| Accounts Payable | $5.91M | $0 | -- | -- |
| **Total Current Liabilities** | $10.17M | $35K | $5.60M | $1.29M |
| **Total Non-Current Liabilities** | $11.93M | $49.43M | $2.89M | $2.89M |
| **Total Liabilities** | $22.10M | $49.47M | $8.49M | $4.18M |
| Common Stock | $23K | $20K | -- | $51 |
| Retained Earnings | -$275.8M | -$115.4M | -$8.28M | -$3.27M |
| **Total Stockholders' Equity** | -$20.75M | -$42.78M | -$38.09M | -$3.27M |
| Total Equity | -$20.75M | -$42.78M | -$38.09M | -$3.27M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $54K | $39K | $103K | $20K | $85K | -- | $2.7K | $12K |
| **Cash & Short-Term Investments** | $54K | $39K | $103K | $20K | $85K | -- | $2.7K | $12K |
| Other Current Assets | -- | $51K | -- | $0 | $0 | -- | -- | $5.98M |
| **Total Current Assets** | $1.26M | $1.19M | $1.22M | $596K | $85K | $14K | $2.7K | $6.00M |
| Property, Plant & Equipment, Net | $750K | $750K | $750K | $750K | $689K | -- | -- | $689K |
| **Total Non-Current Assets** | $750K | $750K | $750K | $750K | $689K | $548K | $9.15M | $689K |
| **Total Assets** | $2.01M | $1.94M | $1.97M | $1.35M | $774K | $562K | $9.15M | $6.68M |
| Accounts Payable | $7.11M | $6.92M | $6.42M | $5.91M | $4.29M | -- | -- | $0 |
| **Total Current Liabilities** | $11.28M | $10.67M | $10.38M | $10.17M | $10.03M | $8.27M | $7.85M | $35K |
| **Total Non-Current Liabilities** | $24.04M | $20.94M | $16.91M | $11.93M | $5.33M | $2.89M | $2.89M | $49.43M |
| **Total Liabilities** | $35.31M | $31.62M | $27.30M | $22.10M | $15.37M | $11.16M | $10.74M | $49.47M |
| Common Stock | $23K | $23K | $23K | $23K | $23K | -- | -- | $20K |
| Retained Earnings | -$288.4M | -$284.7M | -$280.4M | -$275.8M | -$269.6M | -$11.14M | -$10.74M | -$115.4M |
| **Total Stockholders' Equity** | -$33.31M | -$29.67M | -$25.33M | -$20.75M | -$14.59M | -$44.45M | -$43.45M | -$42.78M |
| Total Equity | -$33.31M | -$29.67M | -$25.33M | -$20.75M | -$14.59M | -$44.45M | -$43.45M | -$42.78M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$160.4M | -$4.69M | $633K | -$419K |
| Depreciation & Amortization | $0 | $0 | -- | -- |
| Stock-Based Compensation | $142.4M | $660K | -- | -- |
| Change in Payables | $2.15M | $0 | -- | -- |
| **Operating Cash Flow** | -$5.87M | -$4.89M | -$633K | -$426K |
| Purchases of Investments | -- | -- | -$825K | -$84.15M |
| **Investing Cash Flow** | -- | $43.43M | $39.71M | -$84.15M |
| Share Repurchases | -- | -$43.43M | -$40.54M | -- |
| **Financing Cash Flow** | $5.88M | $4.89M | -$39.69M | $85.40M |
| **Net Change in Cash** | $8.0K | $0 | -$615K | $820K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.63M | -$4.35M | -$4.58M | -$6.16M | -$152.6M | -$999K | -$665K | -$167K |
| Depreciation & Amortization | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| Stock-Based Compensation | $855K | $1.29M | $1.48M | $2.03M | $140.2M | $119K | $92K | -- |
| Change in Payables | $189K | $495K | $511K | $1.62M | $521K | $0 | $0 | -- |
| **Operating Cash Flow** | -$2.22M | -$2.14M | -$2.67M | -$3.60M | -$2.13M | $268K | -$399K | -$1.41M |
| **Financing Cash Flow** | $2.24M | $2.07M | $2.75M | $3.54M | $2.16M | -$220K | $394K | $1.41M |
| **Net Change in Cash** | $15K | -$64K | $83K | -$65K | $30K | $48K | -$5.0K | -$1.0K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -11918.0% | -70.2% | 1.2% | -0.5% |
| Current Ratio | 0.06x | 171.29x | 0.04x | 0.70x |
| Quick Ratio | 0.00x | 0.34x | 0.04x | 0.63x |
| **Net Income Growth (YoY)** | -- | -841.5% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -931.5% | -8629.7% | -8345.7% | -11918.0% | -19951.6% | -556.4% | -35.4% | -61.1% |
| Current Ratio | 0.11x | 0.11x | 0.12x | 0.06x | 0.01x | 0.00x | 0.00x | 171.29x |
| Quick Ratio | 0.00x | 0.00x | 0.01x | 0.00x | 0.01x | -- | 0.00x | 0.34x |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -126.5% |
| Operating Cash Flow Growth (YoY) | -- | -897.8% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
